支气管镜下切片设备的全球市场:规模，占有率，COVID-19影响分析(2023年～2029年):MedCore

全球支气管镜下切片设备的市场规模在2022年估算为1亿3,480万美金。该市场在预测期间内预计将以9.0％的年复合成长率扩大，并达到2亿4,710万美元。

本报告提供全球支气管镜下切片设备市场相关调查，提供市场概要，以及各市场区隔，各地区趋势，竞争情形等资讯。

目录

支气管镜下切片设备市场

• 简介
• 市场概要
• 市场分析与预测
  • 支气管钳市场全体
  • 经支气管细针抽吸市场全体
• 促进因素与阻碍因素
  • 推动市场要素
  • 阻碍市场要素
• 竞争市场占有率分析

The global market for bronchoscopic biopsy devices was valued at $134.8 million in 2022, with an anticipated increase to $247.1 million at a CAGR of 9.0% during the forecast period. The complete report suite on this market encompasses bronchial forceps and transbronchial needle aspiration (TBNA) needle devices as its segments.

MARKET DATA INCLUDED:

• Unit Sales, Average Selling Prices, Market Size & Growth Trends

• Procedure Numbers

• COVID-19 Impact Analysis

• Market Drivers & Limiters

• Market Forecasts Until 2029, and Historical Data to 2019

• Recent Mergers & Acquisitions

• Company Profiles and Product Portfolios

• Leading Competitors

GLOBAL BRONCHOSCOPIC BIOPSY DEVICE MARKET INSIGHTS

A main market driver in the TBNA market is innovation. The newly established products are on the higher end of the price range that will drive up the market growth.

GLOBAL BRONCHOSCOPIC BIOPSY DEVICE MARKET SHARE INSIGHTS

The Global bronchoscopic biopsy device market was led by Olympus, Boston Scientific, and Cook Medical.

In 2022, Olympus emerged as the top competitor in the bronchoscopic biopsy device market, holding a significant market share. The company had a presence in both the disposable bronchial forceps and TBNA markets. Olympus was the leading player in the endobronchial ultrasound (EBUS)-TBNA market, with a major share of the market. Its ViziShot® product line, which has been available in the market for more than ten years, features an extensive range of TBNA needles.

MARKET SEGMENTATION SUMMARY

Bronchoscopic Biopsy Device Market - MedCore - Includes:

• Segments of bronchial forceps and transbronchial needle aspiration (TBNA) needle devices.

RESEARCH SCOPE SUMMARY

• Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)

• Base Year: 2022
• Forecast Period: 2023-2029
• Historical Data: 2019-2022

• Quantitative Data: Market Size, Market Share, Market Growth Rates, Units Sold, Average Selling Prices

• Qualitative Data: COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios

• Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data.

WHY CHOOSE IDATA?

• Experts Only - iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.

• Global Coverage - iData's unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.

• Attention to Detail - It's our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.

• Pricing - When comparing like-with-like, iData's prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.

Table of Contents

Bronchoscopic Biopsy Device Market

• 18.1 Introduction
• 18.2 Market Overview
• 18.3 Market Analysis and Forecast
  • 18.3.1 Total Bronchial Forceps Market
    • 18.3.1.1 Disposable Bronchial Forceps Market
    • 18.3.1.2 Reusable Bronchial Forceps Market
  • 18.3.2 Total Transbronchial Aspiration Needle Market
    • 18.3.2.1 Conventional TBNA Market
    • 18.3.2.2 EBUS-TBNA Market
• 18.4 Drivers and Limiters
  • 18.4.1 Market Drivers
  • 18.4.2 Market Limiters
• 18.5 Competitive Market Share Analysis

LIST OF CHARTS

• Chart 18-1: Bronchoscopic Biopsy Device Market by Segment, U.S., 2019 - 2029
• Chart 18-2: Leading Competitors, Bronchoscopic Biopsy Device Market, U.S., 2022

LIST OF FIGURES

• Figure 18-1: Bronchoscopic Biopsy Device Market by Segment, U.S., 2019 - 2029 (US$M)
• Figure 18-2: Bronchial Forceps Market by Type, U.S., 2019 - 2029 (US$M)
• Figure 18-3: Total Bronchial Forceps Market, U.S., 2019 - 2029
• Figure 18-4: Disposable Bronchial Forceps Market, U.S., 2019 - 2029
• Figure 18-5: Reusable Bronchial Forceps Market, U.S., 2019 - 2029
• Figure 18-6: Transbronchial Aspiration Needle Market by Type, U.S., 2019 - 2029 (US$M)
• Figure 18-7: Total Transbronchial Aspiration Needle Market, U.S., 2019 - 2029
• Figure 18-8: Conventional TBNA Market, U.S., 2019 - 2029
• Figure 18-9: EBUS-TBNA Market, U.S., 2019 - 2029
• Figure 18-10: Leading Competitors, Bronchoscopic Biopsy Device Market, U.S., 2022